Attorney General Todd Blanche to take swift federal action to shut down two city-approved Overdose Prevention Centers in Manhattan, amplifying a high-stakes clash over supervised drug consumption sites funded during the Biden administration.
The Bottom Line
- The Core Demand: Rep. Nicole Malliotakis sent a formal letter on Tuesday pressing U.S. AG Todd Blanche to shut down Manhattan’s East Harlem and Washington Heights injection sites under federal anti-drug statutes.
- The Federal Pressure: The push aligns with a July 2025 executive order signed by President Donald Trump aimed at stripping federal housing and health dollars from programs facilitating illicit drug use.
- The Local Pushback: New York City Health Department officials and local groups defend the facilities, citing a drop in overdose deaths and vital harm-reduction outreach.
The Legal Battle Ground Over Manhattan’s Overdose Prevention Centers
The debate over supervised consumption services has officially reached the desk of the nation’s top prosecutor. At the center of the dispute are two Overdose Prevention Centers (OPCs) operated by the nonprofit OnPointNYC in East Harlem and Washington Heights. These facilities have operated since November 2021—having first launched under former Mayor Bill de Blasio and the city Health Department during the Biden administration—allowing individuals to consume controlled substances like heroin under supervision.
Malliotakis slammed the operations in an interview with Fox News Digital, arguing that the centers attract criminal elements and degrade community quality of life. In her Tuesday letter to U.S. Attorney General Todd Blanche, the Staten Island Republican pointed to Title 21 of the United States Code Section 856. That federal statute makes it unlawful to knowingly open, maintain, or manage any place for the purpose of manufacturing, distributing, or using a controlled substance.
“We don’t want to see this spread throughout the City of New York or the rest of the country, which is why it’s critical for the Department of Justice to step in now to stop these illegally operating heroin injection centers,” Malliotakis stated to Fox News Digital. A DOJ spokesperson confirmed receipt of the letter, noting that appropriate personnel are reviewing the matter carefully.
The Executive Pivot and Congressional Pushback
The renewed scrutiny builds upon executive actions taken by the White House. In July 2025, President Trump signed an executive order directing the Department of Health and Human Services (HHS) and Housing and Urban Development (HUD) to redirect funding away from recipients of federal housing and homelessness assistance that operate safe consumption sites or distribute drug paraphernalia.
According to Malliotakis, that order successfully blocked a $2 million federal grant that the prior administration had approved for the New York facilities. To prevent future policy reversals, Malliotakis also reintroduced the Defund Heroin Injection Centers Act of 2025, legislation designed to codify the executive ban permanently into federal statute.
The friction extends into local municipal politics as well. Malliotakis criticized New York City’s leadership, calling out Mayor Zohran Mamdani following a visit to one of the OnPoint locations earlier this year. “The new mayor, Zohran Mamdani, did go visit one of these facilities and was praising the work they’re doing, which is ludicrous,” Malliotakis said.
Public Health Defense Versus Public Safety Concerns
While federal lawmakers and law enforcement push for closures, city health officials maintain that the supervised sites remain an essential public health intervention. Defending the program, a New York City Health Department spokesperson emphasized the localized impact on mortality rates:
| Entity / Official | Stance | Key Action Taken |
|---|---|---|
| Rep. Nicole Malliotakis | Opposed | Wrote to AG Todd Blanche; introduced Defund Heroin Injection Centers Act |
| OnPointNYC | Supportive | Operates the East Harlem and Washington Heights OPC facilities |
| NYC Health Department | Supportive | Defends sites as life-savers that lower overdose and disease rates |
| U.S. Department of Justice | Reviewing | Confirmed receipt of Malliotakis’s enforcement request letter |
Supporters, including OnPointNYC representatives, have consistently argued that immediate intervention during overdoses saves lives and connects vulnerable populations to long-term care. However, federal critics argue that facilitating consumption on site undermines local safety and violates federal drug laws.
As the Department of Justice reviews the legal status of the Manhattan facilities, the outcome could…
